...
首页> 外文期刊>Clinical and experimental allergy : >Factors influencing the quality of Myrmecia pilosula Myrmecia pilosula (Jack Jumper) ant venom for use in in?vitro and in?vivo diagnoses of allergen sensitization and in allergen immunotherapy
【24h】

Factors influencing the quality of Myrmecia pilosula Myrmecia pilosula (Jack Jumper) ant venom for use in in?vitro and in?vivo diagnoses of allergen sensitization and in allergen immunotherapy

机译:影响MyRMecia pilosula myrmecia pilosula(杰克跳线)蚂蚁毒液中使用的因素,用于体外和βvivo诊断过敏原致敏和过敏原免疫疗法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Summary Background Allergen immunotherapy uses pharmaceutical preparations derived from naturally occurring source materials, which contain water‐soluble allergenic components responsible for allergic reactions. The success of in?vivo and in?vitro diagnoses in allergen sensitization and allergen immunotherapy largely depends on the quality, composition and uniformity of allergenic materials used to produce the active ingredients, and the formulation employed to prepare finished products. Objectives We aimed to examine the factors influencing batch‐to‐batch consistency of Jack Jumper ( Myrmecia pilosula ) ant venom ( JJAV ) in the form of active pharmaceutical ingredient ( AI ) and informed whether factors such as temperature, artificial light and container materials influence the quality of JJAV AI s. We also aimed to establish handling and storage requirements of JJAV AI s to ensure preservation of allergenic activities during usage in the diagnosis of allergen sensitization and in allergen immunotherapy. Methods The quality and consistency of JJAV AI s were analysed using a combination of bicinchoninic acid assay for total protein quantification, HPLC ‐ UV for JJAV allergen peptides quantification, ELISA inhibition for total allergenic potency, SDS ‐ PAGE , AU ‐ PAGE and immunoblot for qualitative assessment of JJAV components, and Limulus Amebocyte Lysate assay for the quantification of endotoxin concentration. API ‐ ZYM and Zymogram assays were used to probe the presence of enzymatic activities in JJAV . Results Pharmaceutical‐grade JJAV for allergen immunotherapy has good batch‐to‐batch consistency. Temporary storage at 4°C and light exposure do not affect the quality of JJAV . Exposure to temperature above 40°C degrades high MW allergens in JJAV . Vials containing JJAV must be stored frozen and in upright position during long‐term storage. Conclusions and Clinical Relevance We have identified factors, which can influence the quality and consistency of JJAV AI s, and provided a framework for appropriate handling, transporting and storage of JJAV to be used for the diagnosis of allergen sensitization and in AIT .
机译:发明内容背景过敏原免疫疗法使用衍生自天然存在的源材料的药物制剂,其含有负担性过敏反应的水溶性过敏组分。体内和体外的成功在过敏原致敏和过敏原免疫疗法的诊断主要取决于用于生产活性成分的过敏材料的质量,组成和均匀性,以及用于制备成品的制剂。我们的目标是检查影响千斤顶(MyRmecia pilosula)蚂蚁毒液(Jjav)的批次到批次一致性的因素,以活性药物成分(AI)的形式,并告知是否温度,人造光和容器材料的影响因素JJAV AI S的质量。我们还旨在建立JJAV AI S的处理和储存要求,以确保在诊断过敏原和过敏原免疫疗法诊断过程中保护过敏性活动。方法采用双链核酸测定的组合分析JJAV AI S的质量和一致性,用于总蛋白质定量,HPLC - UV用于JJAV过敏原肽定量,ELISA抑制总体过敏性效力,SDS - PAGE,AU - 页面和免疫印迹定性评估JJAV组分,贫氨基细胞裂解物测定用于定量内毒素浓度。 API - Zym和Zymofox测定用于探测JJAV中的酶活性存在。结果过敏原免疫疗法的药物级JJAV具有良好的批量批量一致。临时存储在4°C和曝光不影响JJAV的质量。暴露于40°C以上的温度降解JJAV的高MW过敏原。在长期储存期间,含有Jjav的小瓶必须储存冷冻并处于直立位置。结论和临床相关性我们确定了因素,可以影响JJAV AI S的质量和一致性,并提供了适当的处理,运输和储存JJAV的框架,用于诊断过敏原致敏和AIT。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号